Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

254.28
+5.582.24%
Post-market: 254.280.00000.00%19:52 EDT
Volume:516.75K
Turnover:131.04M
Market Cap:16.51B
PE:17.38
High:255.85
Open:248.75
Low:248.55
Close:248.70
52wk High:265.05
52wk Low:121.40
Shares:64.91M
Float Shares:62.69M
Volume Ratio:1.04
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.44
PE(LYR):-43.54

Loading ...

Jazz director Bruce C. Cozadd disposes of Jazz Pharma shares worth $1.1 million

Reuters
·
Apr 04

Jazz Pharmaceuticals to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 02

BRIEF-Pharma Mar Receives Positive Opinion From EMA Recommending Approval Of Zepzelca With Atezolizumab

Reuters
·
Mar 27

Pharma Mar - Phase 3 Imforte Trial, Sponsored by Roche in Collaboration With Jazz Pharmaceuticals

THOMSON REUTERS
·
Mar 27

How New Ziihera and JZP898 Data from AACR 2026 Will Impact Jazz Pharmaceuticals (JAZZ) Investors

Simply Wall St.
·
Mar 22

Jazz Pharmaceuticals Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Mar 20

Jazz Pharmaceuticals price target raised to $232 from $219 at Piper Sandler

TIPRANKS
·
Mar 19

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Mar 19

Jazz Pharmaceuticals Plc : Piper Sandler Raises Target Price to $232 From $219

THOMSON REUTERS
·
Mar 19

Zymework’ partner Jazz to present on Ziihera at 2026 AACR Annual Meeting

TIPRANKS
·
Mar 18

Jazz Pharmaceuticals to present seven oncology studies at AACR 2026

Reuters
·
Mar 18

A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Revenue And Supportive Barclays Commentary

Simply Wall St.
·
Mar 12

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Jazz Pharmaceuticals (JAZZ) and Talkspace (TALK)

TIPRANKS
·
Mar 10

Analysts Are Bullish on These Healthcare Stocks: Rapport Therapeutics, Inc. (RAPP), Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Mar 10

S&P 500 Futures Fall In Premarket Trading; Jazz Pharmaceuticals, Live Nation Ent Lead

Dow Jones
·
Mar 09

Jazz Pharma Director Bruce C. Cozadd Disposes of Common Shares

Reuters
·
Mar 05

Jazz EVP and Chief Legal Officer Neena M Patil Disposes of Common Shares

Reuters
·
Mar 03

Zymeworks Secures $250 Million Royalty-Backed Note Financing From Royalty Pharma

Reuters
·
Mar 02

This Jazz Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday

Benzinga
·
Feb 28

Jazz Pharmaceuticals Advances ONC206 Trial in Rare Tumors, Offering a New Pipeline Catalyst for JAZZ

TIPRANKS
·
Feb 28